Submucous Plexus Neurons (Meissner'S Plexus) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The submucous plexus, also known as Meissner's plexus, is a major component of the enteric nervous system (ENS) located in the submucosa of the gastrointestinal tract. It primarily regulates intestinal secretion, blood flow, and mucosal growth, while also contributing to sensory signaling. Dysfunction of the submucous plexus has been implicated in various neurodegenerative diseases, particularly those involving the gut-brain axis.
¶ Anatomy and Structure
- Located in the submucosa layer of the GI tract
- Most prominent in the small intestine and colon
- Less extensive than the myenteric plexus
| Component |
Description |
| Ganglion |
Clusters of neuronal cell bodies |
| Nerve fibers |
Connect ganglia into network |
| Interstitial cells of Cajal |
Pace-makers in submucosa |
| Vascular innervation |
Control of blood flow |
The submucous plexus contains:
- Secretomotor neurons - Control epithelial secretion
- Vasodilator neurons - Regulate blood flow
- Sensory neurons - Detect luminal content
- Interneurons - Coordinate local circuits
- Motor neurons (minor) - Affect smooth muscle
¶ Neuronal Subtypes and Functions
- Primary function: Stimulate intestinal secretion
- Neurotransmitter: Acetylcholine
- Targets: Crypt epithelial cells
- Effect: Chloride and water secretion
| Neuron Type |
Neurotransmitter |
Function |
| VIP-ergic |
VIP |
Vasodilation, secretion |
| Purinergic |
ATP |
Fast excitatory |
| Nitrergic |
NO |
Vasodilation |
- Detect luminal chemicals
- Respond to bacterial products
- Monitor mucosal environment
-
Chloride secretion
- CFTR activation
- Water follows chloride
- Lubricates intestinal lumen
-
Mucus secretion
- Goblet cell stimulation
- Protective barrier
-
Antimicrobial peptide release
- From Paneth cells
- Host defense
- Active control of mucosal perfusion
- Responds to metabolic demands
- Involved in absorption
¶ Mucosal Growth and Repair
- Trophic effects on epithelium
- Promotes cell proliferation
- Maintains barrier integrity
-
Primary afferent pathways:
- Submucosal neurons → vagal afferents
- To brainstem nuclei
-
Paracrine signaling:
- Local effects on epithelium
- Immune modulation
-
Neuroimmune interactions:
- Communicate with immune cells
- Coordinate defense responses
Pathological Changes:
- α-Synuclein inclusions in submucosal neurons
- May precede brain involvement
- Correlates with GI symptoms
Functional Implications:
- Altered intestinal secretion
- Barrier dysfunction
- Increased intestinal permeability
"Leaky Gut" Hypothesis:
- Compromised mucosal barrier
- Systemic inflammation
- Neuroinflammation acceleration
-
Barrier Dysfunction:
- Intestinal permeability increased
- "Leaky gut" in AD
-
Immune Activation:
- Submucosal immune dysfunction
- Elevated inflammatory markers
-
Cholinergic Signaling:
- Cholinergic anti-inflammatory pathway
- Dysregulated in AD
- Altered intestinal secretions
- Gut barrier dysfunction
- Autonomic involvement
- Correlates with disease progression
- Comorbidity with neurodegenerative diseases
- Common pathophysiological mechanisms
- May provide mechanistic insights
- VIP (Vasoactive Intestinal Peptide)
- ChAT (Choline Acetyltransferase)
- nNOS (neuronal nitric oxide synthase)
- CGRP (Calcitonin Gene-Related Peptide)
- Substance P
- S100β (Enteric glia)
- GFAP (Glial fibrillary acidic protein)
¶ Diagnostic and Therapeutic Implications
- Intestinal permeability measurements
- Mucosal biopsy analysis
- α-Synuclein in submucosal neurons
-
Restore secretion:
- Chloride channel activators
- Lubrication improvement
-
Enhance barrier:
- Tight junction modulators
- Anti-inflammatory agents
-
Neuroprotection:
- Reduce α-synuclein pathology
- Antioxidants
-
Lifestyle interventions:
- Prebiotics
- Probiotics
- Anti-inflammatory diet
| Feature |
Myenteric (Auerbach's) |
Submucous (Meissner's) |
| Location |
Muscle layers |
Submucosa |
| Primary function |
Motility control |
Secretion, blood flow |
| Ganglia density |
Higher |
Lower |
| Effects on CNS |
Via vagus |
Direct sensory |
| In PD |
Lewy bodies |
Lewy bodies |
The study of Submucous Plexus Neurons (Meissner'S Plexus) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Furness JB. (2012). "The enteric nervous system and neurogastroenterology." Nat Rev Gastroenterol Hepatol. 9(5):286-294.
- Breen KC. (2012). "Alpha-synuclein and the gastrointestinal tract." J Parkinsons Dis. 2(2):87-96.
- Savidge TC, et al. (2011). "Enteric glia regulate intestinal barrier function." J Clin Invest. 121(2):782-790.
- Sharkey KA, Mawe GM. (2022). "The enteric nervous system." Physiol Rev. 102(4):1717-1774.
- Cersosimo MG, Benarroch EE. (2012). "Neural control of the gastrointestinal tract: implications for Parkinson disease." Mov Disord. 27(10):1232-1238.
- Clairembault T, et al. (2015). "Enteric alpha-synuclein burden in the substantia nigra of Parkinson disease patients." Mov Disord. 30(3):333-338.
- Forsyth CB, et al. (2011). "Increased intestinal permeability ("leaky gut") in Parkinson's disease." PLoS One. 6(12):e28093.